Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
1
2
3
4
5
6
7
8
9
12
10
11
12
13
14
15
16
17
14
18
19
20
21
22
23
24
25
30
26
27
28
29
30
36
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
Marker Therapeutics-Investor-Presentation 2.19.2019
Marker Therapeutics-Investor-Presentation 2.19.2019
Marker Therapeutics-Investor-Presentation 2.19.2019
Marker Therapeutics-Investor-Presentation 2.19.2019
Marker Therapeutics-Investor-Presentation 2.19.2019
Upcoming SlideShare
Loading in …5
×

Marker Therapeutics-Investor-Presentation 2.19.2019

624 views

Published on

Marker Therapeutics (NASDAQ: MRKR)
Marker Therapeutics, Inc is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

×